HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, recently reassured investors that the company is moving forward and that all aspects of the company are sound. HempFusion made the announcement in response to recent trading activity that saw its share prices fall. The company stated that its material contracts and relationships with key distributors around the world are in good standing and that all aspects of the business, including the five-channel distribution strategy, are in-motion, with no undisclosed events that would cause the share decline. All material information has been disclosed in press releases and other disclosure documents in compliance with disclosure obligations, the company noted. “HempFusion is powering ahead, and I wanted to take the time to reassure investors that the decline in the stock price cannot be explained by an undisclosed development at the Company, as all material information has been disclosed and is readily available,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “We believe the company is in the strongest position it has ever been with significant partnerships, developments, new distributors and international channels deep in development, including a significant sales pipeline, consumers returning to stores, multiple international expansion initiatives and a robust balance sheet, including a strong cash position of approximately US$9.3 million as of December 31, 2020, in addition to the closing of the company’s US$17 million initial public offering on January 6, 2021.”
To view the full press release, visit https://ibn.fm/aa6w9
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.